• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

OEM Contract Manufacturing in Medical Devices, World Market, Vol III – Finished Clinical Products and Systems

$1,995.00 – $6,990.00

Clear
SKU: KLI1378142 Category: Medical Devices Market Research Pages: 200
  • Description
  • Table of Contents
  • Latest reports

Description

Contract Manufacturers are finding opportunities with managers located at OEM corporate headquarters or main manufacturing/assembly operations as they take a hard look at costs and seek outsourcing for cost efficiency.

Once satisfied with outsourcing only a small part of operations, OEM companies are now looking to CMs for finished products and finished computer systems. The highly skilled firms who compete in this area meet the challenges of overburdened OEM device companies demanding a ready-to-launch product.

Kalorama’s OEM Contract Manufacturing in Medical Devices Series presents a total study of market for outsourcing in medical devices. It features an exhaustive three-way market segmentation: It looks at the OEM market revenues by therapeutic area, as well as by segment of device manufacturing. And it also includes revenues by the general device classifications (commodity/non-commodity). This allows those looking at this growing market to get a complete picture of the OEM market.

In Vol. III, Finished Clinical Products , markets are analyzed by the following therapeutic areas:

  • Cardiovascular
  • General Surgery
  • Imaging
  • I.V. Diagnostics
  • Ophthalmology
  • Orthopedics
  • Respiratory
  • Neurology
  • Urology

and the following medical device types:

 

  • Medical Device Implantable Products
  • Medical Single Use Products
  • Surgical Instruments
  • Reusable and Single Use
  • Patient Monitoring Products and Systems
  • Diagnostic Laboratory Equipment and Scientific
  • Instruments
  • Imaging Products and Systems
  • Networking, IT technology and Telemetry Products

 

Revenues are also provided for the following general classification of medical devices:

 

  • Commodity
  • Non-Commodity

 

For each segment, this Kalorama Information study gives current size data and forecasts to 2011, with compound annual growth rates provided for the 2006 to 2011 market period. In addition this exhaustive market analysis, Kalorama Information study reviews Original Equipment Manufacturing Companies (OEMs), and their key capabilities and products, provides an overview of the general medical device market which builds the foundation for O.E.M. potential, and looks at issues and trends in O.E.M. for device manufacturing.

A truly worldwide study, current revenues and forecasts in all therapeutic areas and material processing sectors are provided for U.S., European, Asian, ROW and Global markets.

The following companies are profiled in this report

  • Avail Medical Products Incorporated
  • Merit Medical Systems Incorporated
  • Memry Incorporated
  • TFX Medical Incorporated
  • Saint-Gobain
  • PEC – Polymer Engineering Co.
  • B. Braun O.E.M. Division of B. Braun Medical Incorporated
  • 3M Health Care
  • ATP Engineered Rubber & Plastics Group Incorporated
  • Advanced Polymers Incorporated
  • Creganna Medical Devices
  • Oberg Industries Inc
  • Dupont Medical Packaging
  • Medtech Group Inc
  • Smiths Medical plc
  • Symmetry Medical Inc
  • Synovis International Solutions, Incorporated

The following titles will complete the series:

  • Vol. I: Materials Processing
  • Vol. II: Electronics and Advanced Systems.

Table of Contents

Chapter One: Executive Summary

  • Finished Clinical Products and Systems
  • Scope & Methodology

Chapter TWO: Finished Clinical Products and

  • Systems Sectors
  • Description of Sectors
  • Medical Device Implantable Products
  • Medical Single Use Products
  • Surgical Instruments Reusable and Single Use
  • Patient Monitoring Products and Systems
  • Diagnostic Laboratory Equipment and Scientific Instruments
  • Imaging Products and Systems
  • Networking IT technology and Telemetry Products

Chapter Three: Therapeutic Area  Segments

Chapter FouR: Overall Global Medical  Device Market

  • Worldwide Company Revenues
  • Market Share of Device Companies

Chapter five: Issues and Trends in  the Global O.E.M Market and CMO Market     

  • Outsourcing Challenges
  • The Business Climate
  • Reimbursement Concerns
  • Other Challenges
  • Process Equipment
  • Outsourcing Benefits
  • Offshoring and Partering
  • Changing Relationships
  • MPO Climate
  • A Closer Look at Outsourcing Trends
  • Getting Terms in Writing
  • Impact of Group Purchasing Power (GPO’s) and e-Commerce
  • e-Commerce
  • Problems
  • Product Suitability
  • Global Healthcare Exchange (GHX)
  • Supply Chain Solutions
  • Pharma Solutions
  • Solutions that Benefit the Entire Healthcare Supply Chain
  • Exclusive Regional Dealers
  • Drivers / Trends in Medical Device Distribution
  • Acquisitions
  • Growing Attractiveness of Alternative Care Distribution
  • Distribution Approaches and Commercialization Strategy
  • New market dynamics – Combination Medical Products
  • Innovation to Commodity
  • The Medical Device Market  Model
  • The Outsourcing Picture
  • Outsourcing Challenges
  • The Business Climate
  • Reimbursement Concerns
  • Other Challenges
  • Developing an “X Factor” Differentiates the OEM’s or CMO’s.
  • Outsourcing Benefits
  • Future Potential
  • Expanding Responsibilities
  • Future Development
  • Poised For Growth
  • Offshoring and ParteringChanging Relationships
  • Medical Product Outsourcing
  • A Closer Look at Outsourcing Trends
  • Putting It All in Writing
  • Global Healthcare Exchange (GHX)
  • Supply Chain Solutions
  • Market Intelligence
  • Pharma Solutions
  • Acquisitions
  • Growing Attractiveness of Alternative Care Distribution
  • Distribution Approaches and Commercialization Strategy

Chapter siX: Market Analysis & Data

  • Contract Manufacturing Markets
  • O.E.M ‘s and Risk Adverse Medical Device Segments
  • United States Revenues
  • Group Segments
  • Europe Revenues
  • European Market and Continuous Technological Innovation
  • Group Segments
  • Asia Revenues
  • I.B.M – Case Study For Establishing Manufacturing in China
  • Group Segments
  • Rest of the World Revenues
  • Group Segments
  • Global Revenues
  • Global Market Overview

Chapter Seven: Top O.E.M. Companies

  • Agile, Inc.   (Oracle)
  • Avail Medical Products Corporation
  • Merit Medical , Inc.
  • Smiths Group Plc
  • Symmetry Medical Inc
  • W.L. Gore & Associates Inc
  • Cardinal Health Inc
  • C.R. Bard Inc
  • B.Braun OEM Division
  • Synovis Interventional Solutions Inc

Appendix: Other Key OEM companies

table of exhibits

  • Chapter OnE: Executive Summary
  • Exhibit 1-1: OEM Contract Manufacturing Market in Finished Clinical Products and Systems: 2006, 2008, 2011 (millions)
  • Exhibit 1-2: OEM Contract Manufacturing Market in Finished Clinical Products and Systems by Sector (Medical Device Implantable Products, Medical Single Use Products, Surgical Instruments,Reusable and Single Use, Patient Monitoring Products and Systems, Diagnostic Laboratory Equipment and Scientific
  • Instruments, Imaging Products and Systems, Networking, IT technology
  • and Telemetry Products) Exhibit 1-3: Key European Medical Device Market Segments
  • Exhibit 1-4: Medical Devices Product Flow Chart Process
  • Exhibit 1-5: Examples of Combination Products

Chapter Four: Overall Global Medical  Device Market

  • Exhibit 4-1: The Worldwide Non-Commodity Medical Device Market by Sector (IVD, Imaging, Orthopedics, Cardiovascular, General Surgery, Ophthalmology, Neurology, Urology) …………. 25
  • Exhbit 4-2:  Global Market Share, Medical Device Companies
  • Exhibit 4-3: Top 20 Companies and Reported 2005 Revenues

Chapter five: Issues and Trends in  the Global O.E.M Market and CMO Market

  • Exhibit 5-1: Examples of Combination Products

Chapter siX: Market Analysis & Data

  • Exhibit 6-1: OEM Contract Manufacturing Market in Finished Clinical
  • Products and Systems: 2006, 2008, 2011 (millions)
  • Exhibit 6-2: OEM Contract Manufacturing Market by Sector
  • Exhibit: 6-3: United States Non-Commodity OEM Revenues 2006 – 2011
  • Exhibit 6-4: United States Commodity OEM Revenues 2006 – 2011
  • Exhibit 6-5: United States Estimated Revenues Cardiovascular 2006 – 2011 by Sector (Medical Device Implantable Products, Medical Single Use Products, Surgical Instruments,Reusable and Single Use, Patient Monitoring Products and Systems, Diagnostic Laboratory Equipment and Scientific Instruments, Imaging Products and Systems, Networking, IT technology and Telemetry Products)
  • Exhibit 6-6: United States Estimated Revenues General Surgery 2006 – 2011 by Sector
  • Exhibit 6-7: United States Estimated Revenues Imaging 2006 – 2011 by Sector
  • Exhibit 6-8: United States Estimated Revenues I.V Diagnostics 2006 – 2011 by Sector
  • Exhibit 6-9: United States Estimated Revenues Opthalmology 2006 – 2011 by Sector
  • Exhibit 6-10: United States Estimated Revenues Orthopedics 2006 – 2011 by Sector
  • Exhibit 6-11: United States Estimated Revenues Respiratory 2006 – 2011 by Sector
  • Exhibit 6-12: United States Estimated Revenues Neurology 2006 – 2011 by Sector
  • Exhibit 6-13: United States Estimated Revenues Urology 2006 – 2011 by Sector
  • Exhibit 6-14: Europe Non Commodity OEM Revenues  2006 – 2011
  • Exhibit:6-15: Europe Commodity OEM Revenues  2006 – 2011
  • Exhibit 6-16: Europe Estimated Revenues Cardiovascular 2006 – 2011 by Sector (Medical Device Implantable Products, Medical Single Use Products, Surgical Instruments,Reusable and Single Use, Patient Monitoring Products and Systems, Diagnostic Laboratory Equipment and Scientific Instruments, Imaging Products and Systems, Networking, IT technology and Telemetry Products)
  • Exhibit 6-17: Europe Estimated Revenues General Surgery 2006 – 2011 by Sector
  • Exhibit 6-18: Europe Estimated Revenues Imaging 2006 – 2011 by Sector
  • Exhibit 6-19: Europe Estimated Revenues I.V Diagnostics 2006 – 2011 by Sector
  • Exhibit 6-20: Europe Estimated Revenues Opthalmology 2006 – 2011 by Sector
  • Exhibit 6-21: Europe Estimated Revenues Orthopedics 2006 – 2011 by Sector
  • Exhibit 6-22: Europe Estimated Revenues Respiratory 2006 – 2011 by Sector
  • Exhibit 6-23: Europe Estimated Revenues Neurology 2006 – 2011 by Sector
  • Exhibit 6-24: Europe Estimated Revenues Urology 2006 – 2011 by Sector
  • Exhibit: 6-25: Asia Non-Commodity OEM Revenues  2006 – 2011 by Sector
  • Exhibit: 6-26: Asia Commodity OEM Revenues  2006 – 2011 by Sector
  • Exhibit 6-27: Asia Estimated Revenues Cardiovascular 2006 – 2011 by Sector (Medical Device Implantable Products, Medical Single Use Products, Surgical Instruments,Reusable and Single Use, Patient Monitoring Products and Systems, Diagnostic Laboratory Equipment and Scientific Instruments, Imaging Products and Systems, Networking, IT technology and Telemetry Products)
  • Exhibit 6-28: Asia Estimated Revenues General Surgery 2006 – 2011 by Sector
  • Exhibit 6-29: Asia Estimated Revenues Imaging 2006 – 2011 by Sector
  • Exhibit 6-30: Asia Estimated Revenues I.V Diagnostics 2006 – 2011 by Sector
  • Exhibit 6-31: Asia Estimated Revenues Opthalmology 2006 – 2011 by Sector
  • Exhibit 6-32: Asia Estimated Revenues Orthopedics 2006 – 2011 by Sector
  • Exhibit 6-33: Asia Estimated Revenues Respiratory 2006 – 2011 by Sector
  • Exhibit 6-34: Asia Estimated Revenues Neurology 2006 – 2011 by Sector
  • Exhibit 6-35: Asia Estimated Revenues Urology 2006 – 2011 by Sector
  • Exhibit: 6-35: Rest of The World Non-Commodity OEM Revenues  2006 – 2011 by Sector
  • Exhibit: 5-36: Rest of The World Commodity OEM Revenues  2006 – 2011
  • Exhibit 6-37: Rest of The World Estimated Revenues Cardiovascular 2006 – 2011 by Sector (Medical Device Implantable Products, Medical Single Use Products, Surgical Instruments,Reusable and Single Use, Patient Monitoring Products and Systems, Diagnostic Laboratory Equipment and Scientific Instruments, Imaging Products and Systems, Networking, IT technology and Telemetry Products)
  • Exhibit 6-38: Rest of The World Estimated Revenues General Surgery 2006 – 2011 by Sector
  • Exhibit 6-39: Rest of The World Estimated Revenues Imaging 2006 – 2011 by Sector
  • Exhibit 6-40: Rest of The World Estimated Revenues I.V Diagnostics 2006 – 2011 by Sector
  • Exhibit 6-41: Rest of The World Estimated Revenues Opthalmology 2006 – 2011 by Sector
  • Exhibit 6-42: Rest of The World Estimated Revenues Orthopedics 2006 – 2011 by Sector
  • Exhibit 6-43: Rest of The World Estimated Revenues Respiratory 2006 – 2011 by SectorExhibit 6-44: Rest of The World Estimated Revenues Neurology 2006 – 2011 by Sector
  • Exhibit 6-44: Rest of The World Estimated Revenues Urology 2006 – 2011 by Sector
  • Exhibit: 6-45: Global Non-Commodity OEM Revenues  2006 – 2011 by Sector
  • Exhibit: 6-46: Global Commodity OEM Revenues  2006 – 2011 by Sector
  • Exhibit 6-47: Global Estimated Revneues Cardiology 2006-2011 by Sector (Medical Device Implantable Products, Medical Single Use Products, Surgical Instruments,Reusable and Single Use, Patient Monitoring Products and Systems, Diagnostic Laboratory Equipment and Scientific Instruments, Imaging Products and Systems, Networking, IT technology and Telemetry Products)
  • Exhibit 6-48: Global Estimated Revenues General Surgery 2006 – 2011 by Sector
  • Exhibit 6-49: Global Estimated Revenues Imaging 2006 – 2011 by Sector
  • Exhibit 6-50: Global Estimated Revenues I.V Diagnostics 2006 – 2011 by Sector
  • Exhibit 6-51: Global Estimated Revenues Opthalmology 2006 – 2011 by Sector
  • Exhibit 6-52: Global Estimated Revenues Orthopedics 2006 – 2011 by Sector
  • Exhibit 6-53: Global Estimated Revenues Respiratory 2006 – 2011 by Sector
  • Exhibit 6-53: Global Estimated Revenues Neurology 2006 – 2011 by Sector
  • Exhibit 6-54: Global Estimated Revenues Urology 2006 – 2011 by Sector

 

    Global Market for Medical Devices, 14th Edition
    October 31, 2024
    Remote Patient Monitoring and Telehealth Markets, 13th Edition
    November 27, 2023
    The Global Market for Medical Devices, 13th Edition
    October 25, 2023
    The Market for Medical Devices, 12th Edition
    November 9, 2022

Related products

  • Placeholder image

    Inhaled Insulin: A Market Briefing

    $895.00 – $1,790.00
  • Placeholder image

    Molecular Diagnostics for Blood Banking Applications: Testing volume, cost per test, and market potential

    $995.00 – $1,910.00
  • Placeholder image

    Wound Care Markets, 2nd Edition, Vol II – Burns

    $2,995.00 – $5,990.00
  • Placeholder image

    Wound Care Markets Volume III: Surgical and Trauma Wounds

    $1,875.00 – $3,750.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Prescribing Pharmacists: A Decision Maker EmergesAnalytical Chip Technology – U.S. Markets for Lab on a Chip, DNA/Gene,...
Scroll to top